Mucosal Immune Dysregulation: Eosinophilic Gastrointestinal Disorders and Inborn Errors of Immunity

Eosinophilic gastrointestinal disorders (EGID) are chronic, immune-mediated inflammatory conditions, which may associate inborn errors of immunity (IEI). To characterize features of patients with EGID and IEI. We evaluated the clinical/histopathological/immunophenotypical/genetical characteristics of ten histopathologically confirmed EGID patients. Seven (70%) patients (P1-P7) had eosinophilic esophagitis (EoE) and three (P8-10) (30%) had eosinophilic colitis (EoC). Median ages at the EGID and IEI diagnoses were 4.8 years (0.7–15.5 years) and 6.5 years (0.3–14.5 years), respectively. Recurrent respiratory tract infections ( n = 7, 70%), concomitant allergic diseases ( n = 7, 70%) (asthma ( n = 4, 40%), IgE-mediated food allergy ( n = 4, 40%), atopic dermatitis ( n = 4, 40%), and allergic rhinitis ( n = 2, 20%)), and viral infections ( n = 6, 60%) were present in given number of patients. Low IgG levels were observed in five (50%) patients. Decreased switched memory B cells were observed in four (40%) patients. The IEI diagnoses associated with EGID in this cohort are antibody deficiencies ( n = 3), combined immunodeficiencies ( n = 2), autoinflammatory diseases ( n = 2), EBV associated lymphoproliferation ( n = 1), congenital phagocytic disorders ( n = 1), and Mendelian susceptibility to mycobacterial disease (MSMD) ( n = 1). Both EGID- and IEI-related therapies are given to patients. Two patients (DOCK8 deficiency and chronic granulomatous disease) underwent hematopoietic stem cell transplantation (HSCT), both achieving complete clinical remission for EGID and the underlying IEI. Our findings are consistent with previous reports suggesting a role for mucosal immune dysregulation in IEI-associated EGID. Comprehensive immunological evaluation may be considered in EGID, particularly when one or more clinical features suggestive of IEI are present. EGID may represent an initial manifestation of IEI and remission of EGID was observed after HSCT in selected patients.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Immunology
Published
2026-11-16
DOI
https://doi.org/10.1007/s10875-026-02062-6
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mucosal Immune Dysregulation: Eosinophilic Gastrointestinal Disorders and Inborn Errors of Immunity

Ersin Gümüş, Emre Özdamar, Bülent Enis Şekerel, Arzu Bakırtaş et al.
1 links
Journal of Clinical Immunology
Eosinophilic Esophagitis
article

Mucosal Immune Dysregulation: Eosinophilic Gastrointestinal Disorders and Inborn Errors of Immunity

Ersin Gümüş, Emre Özdamar, Bülent Enis Şekerel, Arzu Bakırtaş, Elif Soyak Aytekin, İnci Nur Saltık‐Temizel, Sinan Sarı, Ümit Murat Şahiner, Dıclehan Orhan, Hasan Özen, İlhan Tezcan, İsmail Yaz, Hülya Demır, Özge Soyer, Barış Kuşkonmaz, Saliha Esenboğa, Deniz N Cağdaş, Deniz İlgün Gürel, Hayriye Hızarcıoğlu Gülşen, Begüm Özbek
article en

Abstract

Eosinophilic gastrointestinal disorders (EGID) are chronic, immune-mediated inflammatory conditions, which may associate inborn errors of immunity (IEI). To characterize features of patients with EGID and IEI. We evaluated the clinical/histopathological/immunophenotypical/genetical characteristics of ten histopathologically confirmed EGID patients. Seven (70%) patients (P1-P7) had eosinophilic esophagitis (EoE) and three (P8-10) (30%) had eosinophilic colitis (EoC). Median ages at the EGID and IEI diagnoses were 4.8 years (0.7–15.5 years) and 6.5 years (0.3–14.5 years), respectively. Recurrent respiratory tract infections ( n = 7, 70%), concomitant allergic diseases ( n = 7, 70%) (asthma ( n = 4, 40%), IgE-mediated food allergy ( n = 4, 40%), atopic dermatitis ( n = 4, 40%), and allergic rhinitis ( n = 2, 20%)), and viral infections ( n = 6, 60%) were present in given number of patients. Low IgG levels were observed in five (50%) patients. Decreased switched memory B cells were observed in four (40%) patients. The IEI diagnoses associated with EGID in this cohort are antibody deficiencies ( n = 3), combined immunodeficiencies ( n = 2), autoinflammatory diseases ( n = 2), EBV associated lymphoproliferation ( n = 1), congenital phagocytic disorders ( n = 1), and Mendelian susceptibility to mycobacterial disease (MSMD) ( n = 1). Both EGID- and IEI-related therapies are given to patients. Two patients (DOCK8 deficiency and chronic granulomatous disease) underwent hematopoietic stem cell transplantation (HSCT), both achieving complete clinical remission for EGID and the underlying IEI. Our findings are consistent with previous reports suggesting a role for mucosal immune dysregulation in IEI-associated EGID. Comprehensive immunological evaluation may be considered in EGID, particularly when one or more clinical features suggestive of IEI are present. EGID may represent an initial manifestation of IEI and remission of EGID was observed after HSCT in selected patients.

Journal of Clinical Immunology
Hacettepe University Hospital (TR), Hacettepe University (TR), Erciyes University (TR), Gazi University (TR)
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Hacettepe Üniversitesi
Good health and well-being
Eosinophilic Esophagitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon